CHICAGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (COSM), an international pharmaceutical company, announced that it has added executive Vassos Efthymiadis to its advisory board. Mr. Efthymiadis is the Managing Director of K&N Efthymiadis S.A. and Vice President of the Redestos Agrotechnology Group, both companies are leaders in agribusiness in Greece. Mr. Efthymiadis is also President of the Hellenic Crop Protection Association, Board Member of the Hellenic Association of Chemical Industries, and Advisory Board Member of the International Hellenic University.
“Vassos Efthymiadis brings a wealth of expertise and experience to our company,” said Grigorios Siokas, Chief Executive Officer of Cosmos Holdings. “His experience with exports to various countries of Southeastern Europe will provide valuable insight as we expand. We are excited to welcome him to the Cosmos team.”
Vassos Efthymiadis stated: “I truly look forward to supporting the Cosmos Holdings team in its quest to expand internationally in the field of pharmaceutical and nutraceutical production and distribution. Coming from a not so dissimilar business segment, I feel confident my experience can contribute to the vision Greg and his great team are shaping regarding the future of the company and the best way to ensure its long-term growth.”
About Cosmos Holdings, Inc.
Cosmos Holdings Inc. is a pharmaceutical wholesaler with offices and warehouses in Thessaloniki and Athens Greece, and in Harlow, UK. The Company has a trans-European network of over 160 clients and vendors which extends to 16 countries including: Germany, United Kingdom, Ireland, United Arab Emirates, Denmark, Italy, France, Singapore, Spain, Lebanon, Skopje, Jordan, Sweden, Poland, Netherlands, and Greece. It also has a direct pharmacy network of over 1100. More information is available at www.cosmosholdingsinc.com.
FORWARD LOOKING STATEMENTS
Except for historical information, this news release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve unknown risks, and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Important factors that might cause such differences are discussed in the Company's filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results could differ materially from those anticipated in these forward-looking statements, if new information becomes available in the future.
Investor Relations Contact: